{"disease":{"id":"adult-onset-immunodeficiency","name":"adult onset immunodeficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05354583","title":"Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"King Chulalongkorn Memorial Hospital","has_results":false},{"nct_id":"NCT03103555","title":"Treatment of Adult-Onset Immunodeficiency With Bortezomib","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":5,"lead_sponsor_name":"Mahidol University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}